Indefinite Delivery Contract SPM20005D2116

This indefinite delivery contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Valued at up to $999,999,999 through December 2025, this single-award indefinite delivery contract serves as the primary vehicle for AmerisourceBergen to deliver a wide variety of essential medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care materials. The contract has no set-aside designation and involves the supply of these pharmaceutical and medical products to the DLA's facilities, primarily located in Chesterbrook, Pennsylvania. The contract is funded by the DLA and involves numerous firm-fixed-price delivery orders issued over the period of performance to meet the diverse healthcare needs of military personnel, veterans, and other federal beneficiaries.

Additionally, AmerisourceBergen holds a smaller indefinite delivery contract, valued at up to $750,000 through May 2024, with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These indefinite delivery contracts demonstrate AmerisourceBergen's significant role as a critical supplier of essential pharmaceutical and medical supplies to various defense and civilian government agencies, leveraging its extensive distribution capabilities to efficiently fulfill the diverse healthcare requirements of the federal government.